Comparison of Once- Versus Twice-Daily Administration of Insulin Detemir, Used With Mealtime Insulin Aspart, in Basal-Bolus Therapy for Type 1 Diabetes Assessment of Detemir Administration in a Progressive Treat-To-Target Trial (ADAPT)DIABETES CAREIF16.62009-01-0140OAAI
Common promoter C516T polymorphism in the ApoB gene is an independent predictor of carotid atherosclerotic disease in subjects presenting a broad range of plasma cholesterol levelsARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYIF7.42004-11-0119PREAI
Common polymorphism in the MTP promoter attenuates the dyslipidemic and proatherogenic effects of excess body weightARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYIF7.42004-08-014PREAI
Magnitude of HDL cholesterol variation after high-dose atorvastatin is genetically determined at the LDL receptor locus in patients with homozygous familial hypercholesterolemiaARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYIF7.42003-11-016PREAI
Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular riskATHEROSCLEROSISIF5.72002-10-0160PREAI
Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjectsARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYIF7.42001-12-01117OAAI
Molecular analysis of apo(a) fragmentation in polygenic hypercholesterolemia - Characterization of a new plasma fragment patternARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYIF7.42001-08-016OAAI
Abnormal fragments of apolipoprotein(a) in plasma of subjects with familial hypercholesterolemiaATHEROSCLEROSISIF5.71999-05-010PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向